036  Ocrelizumab real-world effectiveness in patients with relapsing and primary progressive multiple sclerosis: MuSicalE baseline data

J Hobart; VV Pesch; A Rovira; R Alroughani; G Cutter; L Craveiro; D Dzhenkova; T Kuenzel; R Kantaria; M Trojano

doi:10.1136/jnnp-2022-abn.75

036 Ocrelizumab real-world effectiveness in patients with relapsing and primary progressive multiple sclerosis: MuSicalE baseline data

J Hobart
, VV Pesch
, A Rovira
, R Alroughani
, G Cutter
, L Craveiro
, D Dzhenkova
, T Kuenzel
, R Kantaria
, M Trojano

Peninsula Medical School

Research output: Contribution to conference › Conference paper (not formally published) › peer-review

Original language	English
DOIs	https://doi.org/10.1136/jnnp-2022-abn.75
Publication status	Published - 16 Oct 2020

Access to Document

10.1136/jnnp-2022-abn.75

Cite this

@conference{7dfaa168e7714eceb063ef947918648f,

title = "036 Ocrelizumab real-world effectiveness in patients with relapsing and primary progressive multiple sclerosis: MuSicalE baseline data",

author = "J Hobart and VV Pesch and A Rovira and R Alroughani and G Cutter and L Craveiro and D Dzhenkova and T Kuenzel and R Kantaria and M Trojano",

year = "2020",

month = oct,

day = "16",

doi = "10.1136/jnnp-2022-abn.75",

language = "English",

}

TY - CONF

T1 - 036 Ocrelizumab real-world effectiveness in patients with relapsing and primary progressive multiple sclerosis: MuSicalE baseline data

AU - Hobart, J

AU - Pesch, VV

AU - Rovira, A

AU - Alroughani, R

AU - Cutter, G

AU - Craveiro, L

AU - Dzhenkova, D

AU - Kuenzel, T

AU - Kantaria, R

AU - Trojano, M

PY - 2020/10/16

Y1 - 2020/10/16

U2 - 10.1136/jnnp-2022-abn.75

DO - 10.1136/jnnp-2022-abn.75

M3 - Conference paper (not formally published)

ER -